Joanne Ewing

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

Julio Delgado, Kirsty Thomson, Nigel H. Russell et al. · Blood · 2005 · 166 citations · Full text

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide

Claire Harrison, Adam J. Mead, Anesh Panchal et al. · Blood · 2017 · 163 citations · Full text

Guideline for the investigation and management of eosinophilia

Nauman M. Butt, Jonathan Lambert, Sahra Ali et al. · British Journal of Haematology · 2017 · 162 citations · Full text

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

William Tapper, Amy V. Jones, Róbert Královics et al. · Nature Communications · 2015 · 160 citations · Full text

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Claire Harrison, Jyoti Nangalia, Rebecca H. Boucher et al. · Journal of Clinical Oncology · 2023 · 123 citations · Full text